Unlocking Drug Resistance in Multiple Myeloma: Adipocytes as Modulators of Treatment Response

SIMPLE SUMMARY: Worldwide obesity has nearly tripled in the last fifty years. Obesity is a risk factor for multiple myeloma, contributing to both an increased risk of multiple myeloma development and poor survival outcomes. Obesity is associated with the accumulation of fat cells (adipocytes) in bon...

Descripción completa

Detalles Bibliográficos
Autores principales: Ochiai, Maria, Fierstein, Sara, XsSali, Farouq, DeVito, Nicholas, Purkey, Laura R., May, Rebecca, Correa-Medina, Abraham, Kelley, Mary, Page, Thomas D., DeCicco-Skinner, Kathleen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486466/
https://www.ncbi.nlm.nih.gov/pubmed/37686623
http://dx.doi.org/10.3390/cancers15174347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10486466/
https://www.ncbi.nlm.nih.gov/pubmed/37686623
http://dx.doi.org/10.3390/cancers15174347

Ejemplares similares